Biosimilars: old debates, new arguments

Biosimilars: old debates, new arguments

Saved in:

Bibliographic Details
Main Authors:	José Luis Poveda-Andrés, Virginia Bosó-Ribelles
Format:	Article
Language:	English
Published:	Elsevier 2015-01-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/8978.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Using the Debate Method for Teaching Argumentation to 10-12 Year-Old Children
by: Y. V. Rybka
Published: (2015-02-01)

Savoirs des élèves et débat argumenté
by: Alain Legardez
Published: (2005-01-01)

INVESTIGATING ARGUMENT AS PRODUCT IN THE AMERICAN PRESIDENTIAL DEBATES
by: حسن مرعي, et al.
Published: (2024-12-01)

Ustekinumab Biosimilars
by: Elena Carmona-Rocha, et al.
Published: (2024-11-01)

Biosimilars, the journey has begun
by: Alba Martos-Rosa, et al.
Published: (2015-01-01)

The “Brave New World” of biosimilars: Look before you leap!
by: Lathika Vasu Kamaladevi
Published: (2024-12-01)

An Analysis of the Debate between al-Ṭūsī and al-Kātibī on Contingency Argument
by: Mehmet Tayfun Küçük
Published: (2024-05-01)

Argumentation et impolitesse dans les débats politiques à caractère polémique
by: Nadia Lahiani
Published: (2010-09-01)

Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
by: Mariana P. Miranda-Hernández, et al.
Published: (2018-01-01)

The heart attack of the Polish health service: metaphors, arguments, and emotional appeals in political debates
by: Konrad Juszczyk, et al.
Published: (2025-01-01)

Efficacy and safety of rituximab biosimilar in refractory lupus
by: Nantakarn Pongtarakulpanit, et al.
Published: (2020-10-01)

Debates about Educational Issues: A Pedagogical Strategy to Explore Argumentative Skills in the EFL Classroom
by: Ángela Vanesa Duarte Infante, et al.
Published: (2020-01-01)

Debates about Educational Issues: A Pedagogical Strategy to Explore Argumentative Skills in the EFL Classroom
by: Ángela Vanesa Duarte Infante, et al.
Published: (2020-01-01)

How it affects me: the effects of arguments in public debates on marriage equality for young people in Taiwan
by: I-Ching Lee
Published: (2025-01-01)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
by: Magdalena Kaniewska, et al.
Published: (2019-12-01)

CHANGING IMAGE OF TKIS: ORIGINAL, BIOSIMILAR AND GENERIC OPTIONS
by: Cenk Sunu
Published: (2024-12-01)

Perceptions of Biosimilars Among Healthcare Providers in Saudi Arabia
by: Mohammed Alqahtani, et al.
Published: (2024-11-01)

A review of biosimilars in psoriasis: impacts on efficacy, safety, access, and a first-hand look at biosimilar cost savings within the department of veterans affairs
by: Rebecca Reese, et al.
Published: (2024-12-01)

CURRENT APPROACH TO DEVELOPMENT OF BIOSIMILAR PRODUCTS CONTAINING MONOCLONAL ANTIBODIES AS AN ACTIVE SUBSTANCE – NON-CLINICAL AND CLINICAL STUDIES OF THE FIRST RUSSIAN RITUXIMAB BIOSIMILAR, ACELLBIA®
by: S. M. Alekseev, et al.
Published: (2015-04-01)

Spanish Society of Hospital Pharmacy position paper on biosimilar medicines
by: Noemí Martínez-López de Castro, et al.
Published: (2018-07-01)

Clinical experience with two etanercept biosimilars in Indian patients with spondyloarthritis
by: Ashok Kumar, et al.
Published: (2017-01-01)

Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice
by: Dorota Waz, et al.
Published: (2025-01-01)

Considering middle-classes in Latin America: An update of old debates
by: Isabel Díaz
Published: (2022-09-01)

Investigating the use of chatGPT as a tool for enhancing critical thinking and argumentation skills in international relations debates among undergraduate students
by: Mario de la Puente, et al.
Published: (2024-12-01)

Confidence Region Approach for Assessing Bioequivalence and Biosimilarity Accounting for Heterogeneity of Variability
by: Jianghao Li, et al.
Published: (2015-01-01)

Comparison of Innovative and Conventional Methods in Biosimilar Bridging Studies with Multiple References
by: Pong A, et al.
Published: (2024-12-01)

Nonclinical Similarity of the Biosimilar Candidate ABP 938 with Aflibercept Reference Product
by: Neungseon Seo, et al.
Published: (2024-11-01)

IS IT POSSIBLE TO USE BEVACIZUMAB BIOSIMILAR IN ALL INDICATIONS REGISTERED FOR ORIGINAL DRUG?
by: S. V. Orlov, et al.
Published: (2016-06-01)

New version of derivative consequence argument and response to objections
by: B. V. Faul
Published: (2020-12-01)

The Lexicon of Argumentation for Argument Mining: methodological considerations
by: Patrick Saint Dizier
Published: (2020-12-01)

Are Gill Rackers Involved in Taste Perception and Food Ingestion for Gobio carpathicus (Vladykov, 1925)? A Debate Sustained by Histological Arguments
by: Maria-Catalina MATEI-LATIU, et al.
Published: (2024-11-01)

Clinical Outcomes and Patient Experience of Biosimilar to Biosimilar Infliximab Switching in Patients with Inflammatory Bowel Disease: A Prospective, Single-Centre, Phase IV Interventional Study with a Nested Qualitative Study
by: Clare Harris, et al.
Published: (2023-01-01)

Hazardous drugs: new challenges, new opportunities
by: Silvia Valero García, et al.
Published: (2016-03-01)

Primary school students’ argumentation skills: expression of arguments
by: Vaiva Schoroškienė
Published: (2019-06-01)

Middle sentences: An argument for conceptual structure
by: Luis Manuel Estudillo Díaz
Published: (2012-11-01)

Identification of fibrinogen as a plasma protein binding partner for lecanemab biosimilar IgG
by: Jean‐Pierre Bellier, et al.
Published: (2024-12-01)

Argumentation and the “New Oratory”: the staging of the speaker in investor pitches in English
by: Fiona Rossette-Crake
Published: (2020-12-01)

The argumentation in Galatians
by: M. Hietanen
Published: (2007-12-01)

Argument Realization
by: Karin Kipper
Published: (2021-03-01)

Farewell open letter to SEFH members
by: José Luis Poveda Andrés
Published: (2015-11-01)